“IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy”, Reumatismo, vol. 56, no. s1, pp. 62–73, Mar. 2004, doi: 10.4081/reumatismo.2004.1s.62.